Attorneys on Sheppard Mullin's Life Sciences Team represent companies across the entire industry spectrum and regularly assist clients with M&A, venture capital financing, private placements, initial public offerings, strategic IP portfolio management and licensing, pre-clinical and clinical trials, FDA regulatory approval and launch strategies, and issues that range from acquisitions to antitrust, entity formation to enforceability evaluations, licensing to litigation, patents to product liability and trademarks to transfer pricing.

Our leading FDA Regulatory Team, led by Scott Liebman and Dom DiSabatino, specializes in FDA regulatory and compliance for pharmaceutical, biotechnology, and medical device manufacturers. Our attorneys provide advice on comprehensive compliance programs and risk management strategies, advertising and promotional rules, product labeling, FDA exclusivity, industry guidance, licensing transactions, and regulatory enforcement actions, including DOJ investigations and corporate integrity agreements.